Different acid chlorides (2a-d) reacted with anthranilic acid to produce 2-substituted-3, 1-benzoxazin-4-one (3a-d) which was used as starting material to synthesize some condensed and non-condensed heterocyclic compounds by reaction with nitrogen nucleophiles e.g., hydrazine hydrate and formamide. Some of the newly synthesized analogues were chosen to evaluate their cytotoxic activity against human carcinoma cell lines (HePG2-MCF7-A549). The docking and the cytotoxic activity results revealed that nearly all of the compounds containing N-phenyl aniline showed significant inhibition for the three cell lines.
Introduction
The synthesis of quinazolinone heterocycles has become the cornerstone for synthetic chemists and gained extensive importance in medicinal chemistry because of their diverse pharmacological activities including anti-mycobacterial (1-3), anti-fungal (4), antimalarial (5), antihypertensive (6-8), antihistaminic (9-13), cardiotonic (14), anticancer (15-17), antiviral (18) and thymidylate synthase inhibitory activities (19, 20) .
Substituted quinazolin-3(4H)-ones are among the versatile heterocyclic compounds, as they have a broad spectrum of pharmacological activities like anti-inflammatory (21), anticonvulsant (22-24), analgesic (25), antitubercular (26, 27) and anticancer activities (28) (29) (30) (31) (32) .
Benzoxazine heterocyclic compounds are potent non-steroidal progesterone receptor agonists (33) having many other activities such as anticancer, antiangiogenic (34), antidiabetic and hypolipidemic (35), antidepressant (36) and antiplatelet aggregation activities (37). Epidermal growth factor receptor (EGFR), which is cellular trans-membrane tyrosine kinase, is over-expressed in a significant number of human tumors (e.g., breast, ovarian, colon and prostate). An EGFR expression level often correlates with vascularity and is associated with poor prognosis in patients. Inhibitors of the EGFR protein tyrosine kinase are therefore, expected to have great therapeutic potential in the treatment of malignant and nonmalignant epithelial diseases (38-43). These findings encourage us to synthesize novel 3, 1-benzoxazin-4-one derivatives.
Experimental

Chemistry
All melting points are uncorrected and were 2- phenyl]- 4H-3, 1-benzoxazin-4-one (3d) Yield 85%. Yellow crystals. mp. 235-240 ˚C, IR (KBr, cm , 76.42; H, 4.49; N, 8.91%. Found: C, 76.03; H, 4.20; N, 8.34% .
General procedure for the preparation of compounds (4a, b)
A mixture of (3a (44), 3b (45)) (0.01 mol) and formamide (0.015 mol) was refluxed for 3 h in boiling ethanol (30 mL), then poured into water. The precipitated solid after concentration and cooling was collected by filtration and crystallized from the proper solvent to give (4a, b) . Spectroscopic data for all the compounds are given below.
2-(Pyridin-3-yl) quinazolin-4 (3H)-one (4a):
Yield 65%, White crystals. mp. >300 ˚C, IR (KBr, cm 4.06; N, 18.82%. Found: C, 69.62; H, 3.88 ; N, 18.60%.
2-[(E)-2-(furan-2-yl) ethenyl] quinazolin-4 (3H)-one (4b)
Yield 85%. Black crystals. mp. 170-175 ˚C, IR (KBr, cm -1 ): 1698 (C = O) and 3150 (NH). 1 H NMR (DMSO-d 6 , δ ppm): 6.48 (d, J = 5.4 Hz, 1H, CH), 6.89 (d, J = 2.7 Hz, 1H, CH), 7.11-8.59 (m, 7H, aromatic) , 11.78 (s, 1H, NH, exchangeable with D 2 O).MS: (m/z) ≈ 238 (10%). Anal. Calcd for C 14 H 10 N 2 O 2 (238.24): C, 70.58; H, 4.23; N, 11.76%. Found: C, 70.30; H, 4.08; N, 11.50% .
General procedure for the preparation of compounds (5a, b)
A mixture of (4a, b) (0.01 mol) and chloroacetyl chloride (0.01 mol) was refluxed in boiling N, N-dimethylformamide (DMF) (30 mL) for 3 h. Then the mixture was poured into water. The precipitate was collected by filtration, dried and crystallized from the proper solvent to give (5a, b). Spectroscopic data for all the compounds are given below. taken on electro-thermal capillary melting point apparatus. Infrared spectra were recorded on a Jasco FT/IR-6100, Fourier transforms, Infrared spectrometer (Japan) at cm -1 scale using the KBr disc technique in the Central Services Laboratory, National Research Center, Dokki, Cairo, Egypt.
1 H NMR spectra were determined by using a JEOl EX-270 NMR spectrometer (Japan) at the Central Services Laboratory, National Research Center, Dokki, Cairo, Egypt. The mass spectra were measured with a Finnigan MAT SSQ-7000 mass spectrometer at the Central Services Laboratory, Cairo University, Giza, Egypt. Follow up of the reactions and checking the purity of the compounds were made by TLC on silica gelprecoated aluminum sheets (Type 60, F 254, Merck, Darmstadt, Germany) and the spots were detected by exposure to UV analysis lamp at λ 254/366 nm for few seconds.
General procedure for the preparation of compounds (3a, c, d)
A solution of acid chloride (2a, c, d) (0.01 mol) and anthranilic acid (0.01 mol) in dry pyridine (30 mL) was refluxed for 3 h, the reaction mixture was cooled and poured into cold diluted HCl. The precipitate was collected by filtration and recrystallized from a proper solvent to give (3a, c, d) . Spectroscopic data for all the compounds are given below. Yield 80%. Yellow, white crystals. mp. 210-217 ˚C, IR (KBr, cm -1 ): 1700 (C = O). 1 H NMR (DMSO-d 6 , δ ppm): 7.50-9.03 (m, 8H, aromatic). MS: (m/z) ≈ 224 (10%). Anal. Calcd for C 13 H 8 N 2 O 2 (224.21): C, 69.64; H, 3.60; N, 12.49%. Found: C, 69.43; H, 3.44; N, Yield 85%. Yellow crystals. mp >300 ˚C, IR (KBr, cm -1 ): 1692 (C = O). 1 H NMR (DMSO-d 6 , δ ppm): 7.42-9.21 (m, 8H, aromatic). MS: (m/z) ≈ 224 (15%). Anal. Calcd for C 13 H 8 N 2 O 2 (224.21): C, 69.64; H, 3.60; N, 12.49%. Found: C, 69.55; H, 3.51 ; N, 12.25%.
2-(
-( C h l o ro a c e t y l ) -2 -( p y r i d i n --y l ) quinazolin-4 (3H)-one (5a)
Yield 80%. 
General procedure for the preparation of compounds (6a, b)
A mixture of (5a, b) (0.01 mol) and hydrazine hydrate (0.015 mol) was heated in boiling ethanol (30 mL) under reflux for 4 h. Then the mixture was poured into water. The precipitate was collected by filtration, dried and crystallized from the proper solvent to give (6a, b). Spectroscopic data for all the compounds are given below.
3-(Hydrazinylacetyl)-2-(pyridin-3-yl) quinazolin-4 (3H)-one (6a)
Yield 75%. 
General procedure for the preparation of compounds (8c, d)
A solution of (7c, d) (44) (0.01 mol), was allowed to react with chloroacetyl chloride (0.01 mol) in refluxing pyridine about 2 h and then poured over ice/HCl. The precipitate was collected by filtration and crystallized from the proper solvent to give (8c, d). Spectroscopic data for all the compounds are given below.
-C h l o ro -N -[ 4 -o x o --( p y r i d i n -4 -y l ) quinazolin-3 (4H)-yl] acetamide (8c)
Yield 70% 
2-Chloro-N-{4-oxo-2-[2-(phenylamino) phenyl] quinazolin-3 (4H)-yl} acetamide (8d)
Yield 75% 
General procedure for the preparation of compounds (9c, d)
A solution of compounds (7c, d) (44) (0.01 mol) and chloroacetamide (0.015 mol) was refluxed for 3 h in boiling N, N-dimethylformamide (DMF) (30 mL). Then the mixture was poured into water. The precipitate was collected by filtration, dried and crystallized from the proper solvent to give (9c, d). Spectroscopic data for all the compounds are given below. -4-yl)-3, 4-dihydro-2H-[1, 2, 4] triazino [2, 3-c] 4-dihydro-2H-[1, 2, 4] triazino [2, 3-c] 
6-(Pyridin
6-[2-(Phenylamino) phenyl]-3,
General procedure for the preparation of compounds (10c, d)
A solution of compounds (7c, d) (44) (0.01 mol) and phenyl isothiocyanate (0.01 mol) was refluxed in boiling benzene (30 mL) for 3 h, then concentrated and crystallized from the proper solvent to give (10c, d). Spectroscopic data for all the compounds are given below.
1-[4-Oxo-2-(pyridin-4-yl) quinazolin-3 (4H)-yl]-3-phenylthiourea (10c)
Yield 90% 
1-(4-Oxo-2-(2-(phenylamino) phenyl) quinazolin-3 (4H)-yl)-3-phenylthiourea (10d)
Yield 80% 
General procedure for the preparation of compounds (11c, d)
A solution of (7c, d) (44) (0.01 mol) and benzoyl chloride (0.01 mol) in dry acetone (30 mL) was refluxed for 3 h. Excess solvent was removed and the precipitated solid obtained was crystallized from suitable solvent to obtain (11c, d). Spectroscopic data for all the compounds are given below.
N- [4-oxo-2-(pyridin-4-yl) Procedure: All the following procedures were done in a sterile area using a Laminar flow cabinet biosafety class II level (Baker, SG403INT, Sanford, ME, USA). Cells were suspended in RPMI 1640 medium for HePG2-MCF7 and DMEM for A549. The media are supplemented with 1% antibiotic-antimycotic mixture (10,000 U/mL Potassium Penicillin, 10,000 µg/mL Streptomycin Sulfate and 25 µg/mL Amphotericin B), 1% L-glutamine and 10% fetal bovine serum and kept at 37 °C under 5% CO 2 .
Cells were batch cultured for 10 days, then seeded at concentration of 10x10 3 cells/well in fresh complete growth medium in 96-well Microtiter plastic plates at 37 °C for 24 h under 5% CO 2 using a water jacketed Carbon dioxide incubator (Sheldon, TC2323, Cornelius, OR, USA). Media was aspirated, fresh medium (without serum) was added and cells were incubated either alone (negative control) or with different concentrations of sample to give a final concentration of (100-50-25-12.5-6.25-3.125-0.78 and 1.56 μg/mL). After 48 h of incubation, the medium was aspirated, 40 μL MTT salt (2.5 μg/mL) were added to each well and incubated for a further four hours at 37 °C under 5% CO 2 . To stop the reaction and dissolving the formed crystals, 200 μL of 10% Sodium dodecyl sulphate (SDS) in deionized water was added to each well and incubated overnight at 37 °C. A positive control which composed of 100 µg/mL was used as a known cytotoxic natural agent who gives 100% lethality under the same conditions (47, 48).
The absorbance was then measured using a microplate multi-well reader (Bio-Rad Laboratories Inc., model 3350, Hercules, California, USA) at 595 nm and a reference wavelength of 620 nm. A statistical significance was tested between samples and negative control (cells with vehicle) using independent t-test by SPSS 11 program. DMSO is the vehicle used for dissolution of plant extracts and its final concentration in the cells was less than 0.2%. 
General procedure for the preparation of compounds (12c, d)
A solution of (11c, d) (0.01 mol) with ammonium acetate (0.01 mol) in acetic acid (30 mL) was heated under reflux for 3 h, then poured into water. The precipitated solid after concentration and cooling was collected by filtration and crystallized from suitable solvent to give (12c, d). Spectroscopic data for all the compounds are given below. [1, 2, 4] triazolo [1, 5-c] 
2-
Cytotoxic effect on human cell line (HePG2 -MCF 7 -A549)
Cell viability was assessed by the (Reading of extract/Reading of negative control)-1) x 100. A probit analysis was carried for IC 50 and IC 90 determination using SPSS 11 program.
Molecular docking study
All docking studies were performed using "Internal Coordinate Mechanics" (Molsoft ICM 3.5-0a). Compounds 2d, 3a, 3b, 3d, 4a, 4b, 5a, 5b, 6a, 6b, 7c, 7d, 8d, 9c, 9d, 10c, 10d, 11c, 11d, 12c, 12d were built in Chem Draw Ultra version 11.0 and their energy minimized through Chem3D Ultra version 11.0/MM2, Jop Type: minimum RMS Gradient of 0.100 and saved as MDL Mol File ( * .Mol).
Preparation of small molecule
Generation of Ligand and Enzyme Structures
The crystal structures of EGFR (PDB code: 1M17) complex were retrieved from the RCSB Protein Data Bank (http://www.rcsb.org/pdb/ home/home.do).
We inspect the quality of the PDB file that was used using the PROSESS (Protein Structure Evaluation Suite & Server) (http:// www.prosess.com/index.php) (Figure 1, 2) . In our investigation, the 3D-coordinates in X-ray crystal structure of EGFR in complex with the ligand, Erlotinib (PDB entry 1M17) was used as the receptor model in EGFR docking simulation (Figure 3 ). All bound waters ligands and cofactors were removed from the protein.
Docking using Molsoft ICM 3.5-0 a program
The conversion of our PDB file into an ICM object involves the addition of hydrogen bonds, assignment of atom types and charges from the residue templates, then perform ICM small molecule docking through setup the receptor, review and adjust binding site makes receptor maps, then start docking simulation, followed by displaying the results. ICM stochastic global optimization algorithm attempts to find the global minimum of the energy function that include five grid potentials describing the interaction of the flexible ligand with the receptor and internal conformational energy of the ligand, during this process a stack of alternative low energy conformations is saved. All inhibitors were compared according to the best binding free energy (minimum) obtained among all the run.
Results and Discussion
Chemistry Different acid chlorides namely, pyridine-3-carbonyl chloride, (2E)-3-(furan-2-yl) prop-2-enoyl chloride, pyridine-4-carbonyl chloride and 2-(phenylamino) benzoyl chloride 2a-d, Figure 1 . Quality of the PDB file that was used using the Prosess. Figure 1 . Quality of the PDB file that was used using the Prosess. 
In-vitro Antitumor Screening against A549, HePG2 and MCF7 cell lines
The cytotoxic potencies of compounds 2d, 3a, 3b, 3d, 4a, 4b, 5a, 5b, 6a, 6b, 7c, 7d, 8d, 9c, 9d, 10c, 10d, 11c, 11d, 12c , 12d against a panel of three human tumor cell lines were investigated and compared with the reference drug doxorubicin (Table 1) . The human tumor cell line panel consisted of breast carcinoma (MCF7), liver carcinoma (HePG2) and lung carcinoma (A549) using MTT assay. Tumor cells were incubated either alone (negative control) or with different concentrations of the test compounds (100-50-25-12.5-6.25-3.125-0.78 and 1.56 µM). With regard to sensitivity against individual cell lines, this class is more effective on hepatocellular carcinoma more than other two cell lines. Compound 10c showed selective potency Scheme 1. Synthesis of the newly 3, 1-benzoxazin-4-one derivatives.
benzoyl chloride to give compounds 9-11 (c, d), respectively (Scheme 2). Compounds 11c, d reacted with ammonium acetate to give N-phenyl-2-(substituted-[1, 2, 4] triazolo [1, 5-c] Table 2 . However, compounds 11d and 9d showed selective potency against HePG2 cell line with IC 50 53.4 and 66.7 µg/mL, respectively, as shown in Table 3 and compounds 4b and 8d for MCF7 cell line with IC 50 81.9 and 90.5 µg/mL, respectively as shown in Table 4 . However, compounds 7d, 3d and 2d showed effectiveness against all cell lines with IC 50 (62.6, 85.0 and 92.1 µg/mL), (65.1, 82.9 and 77.6 µg/mL) and (75.8, 81.9 and 86.1 µg/mL) for HePG2, MCF7 and A549 as shown in Table  3 , 4, 2, respectively. In addition, compounds 10d and 6a displayed selective potency against A549 and HePG2 cell lines with IC 50 of 88.4, 92.1 and 45.6, 32.8 µg/mL concentrations, respectively as shown in Table 2 , 3. While compound 12d displayed selective potency against HePG2 and MCF7 cell lines with IC 50 33.3 and 87.4 µg/mL, respectively. Moreover, Compounds 6a and 12d considered the most potent compounds against the HePG2 cell line, while compounds 7d, 3d, 9d, 10d, 11d and 2d possessed moderate antitumor activity compared to positive control doxorubicin. Compounds 2d, 3a, 3b, 3d, 4a, 4b, 5a, 5b, 6a, 6b, 7c, 7d, 8d, 9c, 9d, 10c, 10d, 11c, 11d, 12c, 12d were used for docking study. All the calculations were performed using "Internal Coordinate Mechanics" (Molsoft ICM 3.5-0a). Molecular modeling docking studies is performed and ICM score values (49-51) combined with hydrogen bonds formed with the surrounding elemental analyses and IR, 1 H NMR and mass spectral data. IR spectra of the compounds 6a, b exhibited characteristic absorption bands in the range 3174-3444 cm -1 due to the respective NH and NH2. 1 H NMR (DMSO-d6) spectra of compounds 6a, b revealed signals at δ 3.70-3.80 ppm and 10.49-11.21 ppm representing NH2 and NH groups, respectively. 20.6% at 100ppm
Docking analysis
65.1% at 100ppm 126.3 77.6 3d 22.3% at 100ppm
51.7% at 100ppm 145.4 92.1 6a
69.6% at 100ppm 121.4 72.2 10c 54.5% at 100ppm 142.2 88.4 10d
13.9% at 100ppm 
78.6% at 100ppm 109.6 65.1 3d
84.5% at 100ppm 103.9 62.6 7d 40.6% at 100ppm
94.2% at 100ppm 79.1 45.6 10d 0% at 100ppm 
61.1% at 100ppm 131.8 82.9 3d
58.6% at 100ppm 132.1 81.9 4b
60.7% at 100ppm 132.2 85.0 7d 55.4% at 100ppm 143.1 90.5 8d
57.5% at 100ppm 137.1 87.4 12d amino acid residues help to predict the correct binding geometry for each binder at the active site. The molecular docking was performed into the hydrophobic site of EGFR with the aim to predict antitumor activity of compounds of the study (2d, 3a, 3b, 3d, 4a, 4b, 5a, 5b, 6a, 6b, 7c, 7d, 8d, 9c, 9d, 10c, 10d, 11c, 11d, 12c, 12d) against A549, HePG2 and MCF7 cell lines.
As shown in Table 5 , Erlotinib (ligand) reveals ICM score of -90.54 and forms 3 H bonds with Met769, Cys773 and Gln767 (Figure 3) , the target compounds elicited binding affinities (ICM scores range from -40.86 to -73.01). Compounds 10d, 12d, 8d, 11d, 9d showed activity probably due to their high ICM scores which ranged from -62.33 to -73.01 however compounds 4a, 6b, 7c, 5a are biologically inactive; they have low ICM scores of ranges from -40.86 to -50.44.
Conclusion
A novel series of some new quinazolin derivatives were synthesized and evaluated as antitumor agents against human carcinoma cell lines (HePG2-MCF7-A549). The antitumor activity results exhibited that, compounds 2d, 3d, 6a, 7d, 10c, 10d showed significant and selective inhibition for A549 (Table 2) (Figure 4 ). On the other hand, compounds 2d, 3d, 6a, 7d, 9d, 10d, 11d, 12d showed significant and selective inhibition for HePG2 (Table 3 ) ( Figure 5 ). Compounds 2d, 3d, 4b, 7d, 8d, 12d showed significant inhibition for MCF7 (Table 4 ) (Figure 6 ) comparing to the used reference drug Doxorubicin. Docking result shows that compound 10d have high ICM score -73.01 forms 3 H bonds with Lys721 and Asp831 (Figure 7) . However, compound 5a has low ICM scores -40.86 forms 3 H bonds with Asn784, Ile 785 and Gly 959 (Figure 8) . 
Structure-activity relationship
The activity of the tested compounds could be correlated to structure variation and modifications. By investigating the variation in the selectivity of the tested compounds over the three cell lines, it was revealed that: (1) the activity of the designed compounds is dependent upon the substituent at the R positions. The obtained screening results showed that, nearly all of the compounds containing N-phenyl aniline showed significant inhibition for the tested three cell lines (2). Cyclization of compound 2d afforded compound 3d (44) with the increase in activity against A549 with IC 50 values 86.1 and 77.6 µg/mL, respectively and for HePG2 with IC 50 values 75.8 and 65.1 µg /mL, respectively, while result in a little decrease in activity against MCF7 with IC 50 values 81.9 and 82.9 µg/mL, respectively (Table 2, 3, 4) (3). Compounds which haveCSNHPh group were found to be more active in the biological activities discussed in this paper than compounds which have -H. These results suggest that electron withdrawing hydrophilic substitutes (e.g.,-CSNHPh) are more desirable for achieving the desired activity. Also Certain isothiocyanates have also been shown to bind to the mutated p53 proteins found in many types of tumors, causing an increase in the rate of cell death (4) . Compounds which have CO 2 CH 2 Cl yielded the least active series of compounds in this study. Which suggests that electron withdrawing groups with lipophilic characteristics like-Cl may not be an ideal substitution to get the good activity of the designed compounds.
